Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

KRYSKRYS
Showing 8 of 29 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in KRYSTAL BIOTECH INC

Yes. Charles Schwab Investment Management holds 254,828 shares of KRYS (Krystal Biotech), worth $94.7M, as of its Q2 2026 13F filing. It increased the position by 12,842 shares (+5.3%) from Q1 2026. Charles Schwab Investment Management has held KRYS since Q2 2019, across 29 quarterly 13F filings.

Current Value

$94.7M

Current Shares

254,828

Total Value Change

+$51M

Total Shares Change

+14,612

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
254,828
+5.3%
$94.7M0.0%$371.67
32
2026-Q1
Decreased
241,986
-0.3%
$62.5M0.0%$263.80
0
2025-Q4
Decreased
242,774
-0.0%
$59.9M0.0%$247.88
0
2025-Q3
Decreased
242,863
-1.4%
$42.9M0.0%$176.75
0
2025-Q2
Decreased
246,180
-1.7%
$33.8M0.0%$138.88
0
2025-Q1
Increased
250,514
+3.0%
$45.2M0.0%$183.92
30
2024-Q4
Increased
243,170
+1.2%
$38.1M0.0%$159.80
29
2024-Q3
Increased
240,216
+9.0%
$43.7M0.0%$177.14
32

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used